Researchers compare the effectiveness and acceptability of oral monotherapy with psychedelics for the treatment of depressive symptoms.
Canada approves AstraZeneca-Merck’s prostate cancer therapy
The trial evaluated Lynparza along with abiraterone versus placebo with abiraterone in male mCRPC patients. Credit: Image Point Fr / Shutterstock.com. AstraZeneca and Merck (MSD)